Hepatitis B Virus Vaccines
Reports outline hepatitis b virus vaccines research from Tor Vergata University, Department of Public Health
Published in Hepatitis Weekly, November 27th, 2006
New research, "Extended double-dosage HBV vaccination after liver transplantation is ineffective, in the absence of lamivudine and prior wash-out of human Hepatitis B immunoglobulins," is the subject of a report. According to a study from Italy, "The recommended prophylaxis against hepatitis B virus recurrence after liver transplantation based on hepatitis B immunoglobulins and lamivudine is highly expensive. A recent study reported a significant anti-HBs (antibodies against hepatitis B surface antigen) response after a reinforced vaccination against hepatitis B virus, a result not confirmed in a study from our group."
"Concomitant lamivudine treatment and the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-11-27)
More Articles from Hepatitis Weekly
- Hepatitis A Virus
Researchers at Afyon Kocatepe University release new data on hepatitis a virus in children - Hepatitis B Virus Therapy
Studies from Health Science Center, Department of Biochemistry and Molecular Biology further understanding of hepatitis b virus therapy - Hepatitis C Virus
Findings from Scripps Research Institute, Department of Molecular and Experimental Medicine provide new insights into hepatitis c virus - Hepatitis C Virus
Reports outline hepatitis c virus study findings from Osaka University, Department of Molecular Virology - Hepatitis C Virus Cell Biology
Investigators at Scripps Research Institute target hepatitis c virus cell biology - Hepatitis C Virus Gene Therapy
Scientists at Osaka University, Department of Molecular Virology release new data on hepatitis c virus gene therapy - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
